The American Chemical Society (ACS) has announced plans to launch a new journal, ACS Chemical Neuroscience, focusing on the molecular basis of neurological disease. Slated for launch in January 2010, the journal targets a growing demand for publication of neuroscience research and represents an expansion of the ACS journal portfolio relating to biological chemistry. Dr. Craig W. Lindsley of Vanderbilt University School of Medicine will be the Editor-in-Chief of the journal.
A bimonthly, ACS Chemical Neuroscience will focus on the molecular aspects of neurological science in both health and disease. Topics expected in the peer-reviewed, online-only publication include nerve activators and receptors; nerve growth and development; nerve imaging; pain and sensory processing; and the diagnosis and treatment of neurological diseases.
In addition, the journal will utilise ACS' award-winning Web delivery platform to publish short features as well as peer-reviewed letters, articles and reviews. The publication will include regular commentary features to discuss standards in the field as well as develop connections between technological advancements and applications. These features will serve to engage the diverse group of scientists working in the multidisciplinary neuroscience field.
Search for more such STM tools/services/products in K-Store
Discuss this NEWS
